EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TCM‐Guided Targeted Therapies Against NLRP3 Inflammasome in NAFLD

Yanxia Zhang iD

Immunity, Inflammation and Disease · 2026-06 · 14 (6)

DOI: 10.1002/iid3.70474 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 17.06.2026. Verfasst von Yanxia Zhang. Beteiligte Einrichtung: Shandong Xinzhonglu Traditional Chinese Medicine Hospital, Jinan, Shandong, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Non-alcoholic Fatty Liver Disease, Inflammasomes, Medicine, Chinese Traditional. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Xinzhonglu Traditional Chinese Medicine Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐alcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder driven by inflammation, in which the NLRP3 inflammasome plays a central role. Current targeted inhibitors face challenges in patient stratification and long‐term safety.

Methods

A narrative literature review was conducted using PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), and Google Scholar from database inception to February 2026. Search terms included combinations of “non‐alcoholic fatty liver disease”, “NAFLD”, “NASH”, “NLRP3 inflammasome”, “traditional Chinese medicine”, “TCM”, “herbal medicine”, “syndrome differentiation”, and “precision medicine”. Peer‐reviewed original articles, systematic reviews, and clinical studies addressing NLRP3 in NAFLD or TCM‐based interventions targeting this pathway were prioritized.

Results

TCM syndrome patterns (e.g., damp‐heat, phlegm‐damp) correlate with distinct NLRP3 activation states and inflammatory phenotypes. Herbal compounds such as berberine and curcumin, as well as classical TCM formulae, exert multi‐target effects by suppressing NLRP3 inflammasome assembly, enhancing antioxidant defenses, and modulating the gut‐liver axis. Based on this evidence, we propose an integrative “TCM Syndrome–NLRP3 Molecular Endotype–Precision Targeted Therapy” model that links specific TCM syndromes to canonical, non‐canonical, or sustained NLRP3 activation, thereby providing hypothesis‐driven strategies for personalized intervention.

Discussion

This integrative framework bridges TCM holistic principles with modern inflammasome biology. It provides a theoretical basis for personalized, biomarker‐driven NAFLD therapies, highlighting the synergy between traditional medicine and precision hepatology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinNon-alcoholic Fatty Liver DiseaseInflammasomesMedicine, Chinese TraditionalDrugs, Chinese HerbalHumansAnimals

Stichwörter der Autor:innen

NLRP3 inflammasomenon‐alcoholic fatty liver disease (NAFLD)precision medicinetherapeutic strategiestraditional Chinese medicine (TCM)

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNLRP3 protein, humanDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Shandong Xinzhonglu Traditional Chinese Medicine Hospital, Jinan, Shandong, China.

ORCID-Profile: Yanxia Zhang

Förderung

  • Shandong Xinzhonglu Traditional Chinese Medicine Hospital

Zitieren

APA

Zhang, Y. (2026). TCM‐Guided Targeted Therapies Against NLRP3 Inflammasome in NAFLD. Immunity, Inflammation and Disease, 14(6). https://doi.org/10.1002/iid3.70474

Vancouver

Zhang Y. TCM‐Guided Targeted Therapies Against NLRP3 Inflammasome in NAFLD. Immunity, Inflammation and Disease. 2026;14(6). doi:10.1002/iid3.70474

BibTeX
@article{Zhang2026,
  author = {Zhang, Yanxia},
  title = {TCM‐Guided Targeted Therapies Against NLRP3 Inflammasome in NAFLD},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1002/iid3.70474}
}
Kostenlos starten →